Literature DB >> 24950944

Glutamate and GABA-metabolizing enzymes in post-mortem cerebellum in Alzheimer's disease: phosphate-activated glutaminase and glutamic acid decarboxylase.

G Sh Burbaeva1, I S Boksha, E B Tereshkina, O K Savushkina, T A Prokhorova, E A Vorobyeva.   

Abstract

Enzymes of glutamate and GABA metabolism in postmortem cerebellum from patients with Alzheimer's disease (AD) have not been comprehensively studied. The present work reports results of original comparative study on levels of phosphate-activated glutaminase (PAG) and glutamic acid decarboxylase isoenzymes (GAD65/67) in autopsied cerebellum samples from AD patients and matched controls (13 cases in each group) as well as summarizes published evidence for altered levels of PAG and GAD65/67 in AD brain. Altered (decreased) levels of these enzymes and changes in links between amounts of these enzymes and other glutamate-metabolizing enzymes (such as glutamate dehydrogenase and glutamine synthetase-like protein) in AD cerebella suggest significantly impaired glutamate and GABA metabolism in this brain region, which was previously regarded as not substantially involved in AD pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24950944     DOI: 10.1007/s12311-014-0573-4

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  63 in total

1.  Cerebellar projections to the prefrontal cortex of the primate.

Authors:  F A Middleton; P L Strick
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

2.  Brain region-specific monoaminergic correlates of neuropsychiatric symptoms in Alzheimer's disease.

Authors:  Yannick Vermeiren; Debby Van Dam; Tony Aerts; Sebastiaan Engelborghs; Peter P De Deyn
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 3.  The structural and functional heterogeneity of glutamic acid decarboxylase: a review.

Authors:  M G Erlander; A J Tobin
Journal:  Neurochem Res       Date:  1991-03       Impact factor: 3.996

4.  Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase.

Authors:  H Asada; Y Kawamura; K Maruyama; H Kume; R G Ding; N Kanbara; H Kuzume; M Sanbo; T Yagi; K Obata
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

5.  Brain-decarboxylase activities as indices of pathological change in senile dementia.

Authors:  D M Bowen; P White; R H Flack; C B Smith; A N Davison
Journal:  Lancet       Date:  1974-06-22       Impact factor: 79.321

6.  Brain glutamate decarboxylase in Parkinson's disease with particular reference to a premortem severity index.

Authors:  J C Monfort; F Javoy-Agid; J J Hauw; B Dubois; Y Agid
Journal:  Brain       Date:  1985-06       Impact factor: 13.501

7.  GABA production by glutamic acid decarboxylase is regulated by a dynamic catalytic loop.

Authors:  Gustavo Fenalti; Ruby H P Law; Ashley M Buckle; Christopher Langendorf; Kellie Tuck; Carlos J Rosado; Noel G Faux; Khalid Mahmood; Christiane S Hampe; J Paul Banga; Matthew Wilce; Jason Schmidberger; Jamie Rossjohn; Ossama El-Kabbani; Robert N Pike; A Ian Smith; Ian R Mackay; Merrill J Rowley; James C Whisstock
Journal:  Nat Struct Mol Biol       Date:  2007-03-25       Impact factor: 15.369

8.  Inhibition of different molecular forms of brain glutamic acid decarboxylase (GAD) with ATP.

Authors:  T Turský; M Lassánová
Journal:  J Neurochem       Date:  1978-04       Impact factor: 5.372

9.  Implications for altered glutamate and GABA metabolism in the dorsolateral prefrontal cortex of aged schizophrenic patients.

Authors:  Martin R Gluck; Rohan G Thomas; Kenneth L Davis; Vahram Haroutunian
Journal:  Am J Psychiatry       Date:  2002-07       Impact factor: 18.112

Review 10.  Ammonium metabolism in humans.

Authors:  Maria M Adeva; Gema Souto; Natalia Blanco; Cristóbal Donapetry
Journal:  Metabolism       Date:  2012-08-24       Impact factor: 8.694

View more
  7 in total

1.  Glutaminase C overexpression in the brain induces learning deficits, synaptic dysfunctions, and neuroinflammation in mice.

Authors:  Yi Wang; Yuju Li; Runze Zhao; Beiqing Wu; Blaise Lanoha; Zenghan Tong; Justin Peer; Jianhui Liu; Huangui Xiong; Yunlong Huang; Jialin Zheng
Journal:  Brain Behav Immun       Date:  2017-06-15       Impact factor: 7.217

2.  In Silico Preliminary Association of Ammonia Metabolism Genes GLS, CPS1, and GLUL with Risk of Alzheimer's Disease, Major Depressive Disorder, and Type 2 Diabetes.

Authors:  Jeddidiah W D Griffin; Ying Liu; Patrick C Bradshaw; Kesheng Wang
Journal:  J Mol Neurosci       Date:  2018-02-13       Impact factor: 3.444

3.  Alterations in Cerebral Cortical Glucose and Glutamine Metabolism Precedes Amyloid Plaques in the APPswe/PSEN1dE9 Mouse Model of Alzheimer's Disease.

Authors:  Jens V Andersen; Sofie K Christensen; Blanca I Aldana; Jakob D Nissen; Heikki Tanila; Helle S Waagepetersen
Journal:  Neurochem Res       Date:  2016-09-29       Impact factor: 3.996

Review 4.  The Emerging Role of Altered Cerebellar Synaptic Processing in Alzheimer's Disease.

Authors:  Eriola Hoxha; Pellegrino Lippiello; Fabio Zurlo; Ilaria Balbo; Rita Santamaria; Filippo Tempia; Maria Concetta Miniaci
Journal:  Front Aging Neurosci       Date:  2018-11-27       Impact factor: 5.750

5.  Astrocytes in mouse models of tauopathies acquire early deficits and lose neurosupportive functions.

Authors:  Marta Sidoryk-Wegrzynowicz; Yannick N Gerber; Miriam Ries; Magdalena Sastre; Aviva M Tolkovsky; Maria Grazia Spillantini
Journal:  Acta Neuropathol Commun       Date:  2017-11-29       Impact factor: 7.801

6.  Reduced density of glutamine synthetase immunoreactive astrocytes in different cortical areas in major depression but not in bipolar I disorder.

Authors:  Hans-Gert Bernstein; Gabriela Meyer-Lotz; Henrik Dobrowolny; Jana Bannier; Johann Steiner; Martin Walter; Bernhard Bogerts
Journal:  Front Cell Neurosci       Date:  2015-08-10       Impact factor: 5.505

7.  Serial deletion reveals structural basis and stability for the core enzyme activity of human glutaminase 1 isoforms: relevance to excitotoxic neurodegeneration.

Authors:  Yuju Li; Justin Peer; Runze Zhao; Yinghua Xu; Beiqing Wu; Yi Wang; Changhai Tian; Yunlong Huang; Jialin Zheng
Journal:  Transl Neurodegener       Date:  2017-04-20       Impact factor: 8.014

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.